PMA device
Freestyle Navigator Continuous Glucose Monitoring System
Abbott Laboratories · Sensor, Glucose, Invasive (MDS, Class III) · First FDA decision May 15, 2008, newest Jan 14, 2011Diabetes
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
5
PMA pathway
Device trials
24
Naming "Freestyle Navigator"
MAUDE reports
2
Brand "Freestyle Navigator", since 2015
PubMed studies
50
Mentioning "Freestyle Navigator"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Freestyle Navigator Continuous Glucose Monitoring System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 5 of 5 decisions filed under this name.
- FREESTYLE NAVIGATOR CONTINUOUS GLUCOSE MONITORING SYSTEMPMA supplement
P050020-S022 · Decided Jan 14, 2011 · 346 days after receipt · Normal 180 Day Track
Device type: Sensor, glucose, invasive (MDS) · Laboratory Medicine & Pathology
- FREESTYLE NAVIGATOR CONTINUOUS GLUCOSE MONITORING SYSTEMPMA supplement
P050020-S011 · Decided Apr 13, 2009 · 49 days after receipt · Normal 180 Day Track No User Fee
Device type: Sensor, glucose, invasive (MDS) · Laboratory Medicine & Pathology
- FREESTYLE NAVIGATOR CONTINUOUS GLUCOSE MONITORING SYSTEMPMA supplement
P050020-S010 · Decided Sep 25, 2009 · 235 days after receipt · Normal 180 Day Track
Device type: Sensor, glucose, invasive (MDS) · Laboratory Medicine & Pathology
2 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Freestyle Navigator", any status and sponsor, newest update first.
- Navigator 1.5 Accuracy StudyCompleted
Abbott Diabetes CarePublic (ABT)
NCT01076218 · 57 participants · Start Apr 2008 · Primary completion Jul 2008
Device: FreeStyle Navigator Continuous Glucose Monitoring System Version 1.5 · For: Diabetes Mellitus
Sites: Walnut Creek, California; Renton, Washington
University of PennsylvaniaAcademic, hospital or other
NCT01474889 · 37 participants · Start Oct 2011 · Primary completion May 2016
Device: RT-CGM · For: Hypoglycemia Unawareness; Type 1 Diabetes; Healthy
Sites: Philadelphia, Pennsylvania · 3 sites in all
- Can Continuous Glucose Measurements Help Diabetic Patients Treated With an Implantated Pump?Terminated
University Hospital, MontpellierAcademic, hospital or other
NCT03048227 · 15 participants · Start Apr 21, 2017 · Primary completion Mar 21, 2020
Device: Continuous Glucose Measurement (CGM) · For: Type1diabetes
Sites: Nancy, France; Bordeaux, France; Corbeil-Essonnes, France · 10 sites in all
21 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Freestyle Navigator", and for the whole product code for context.
This brand
2 reports: 2 malfunction, 0 injury, 0 death
Whole product code MDS
232,139 reports: 226,671 malfunction, 5,201 injury, 215 death
Newest reports for this brand
- FREESTYLE NAVIGATORMalfunction
2954323-2015-00067 · Received Feb 5, 2015 · Event dated Jan 13, 2015
Device type: Sensor, Glucose, Invasive (MDS)
Device problem as coded: Crack
Patient problem as coded: No Known Impact Or Consequence To Patient
- FREESTYLE NAVIGATORMalfunction
2954323-2015-00068 · Received Feb 5, 2015 · Event dated Jan 15, 2015
Device type: Sensor, Glucose, Invasive (MDS)
Device problem as coded: Crack
Patient problem as coded: No Known Impact Or Consequence To Patient
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0820-2010 · Started Apr 14, 2009 · Posted by FDA Apr 30, 2010
Reason given: Potential failure or inaccurate readings--the device's plastic housing near the battery compartment may crack, and allow moisture to enter.
Cause as FDA categorized it: Process control · Device type: Sensor, Glucose, Invasive (MDS)
Z-0821-2010 · Started Apr 14, 2009 · Posted by FDA Apr 30, 2010
Reason given: Potential failure or inaccurate readings--the device's plastic housing near the battery compartment may crack, and allow moisture to enter.
Cause as FDA categorized it: Process control · Device type: Sensor, Glucose, Invasive (MDS)
Z-1444-2010 · Started Apr 14, 2009 · Posted by FDA Apr 30, 2010
Reason given: Potential failure or inaccurate readings--the device's plastic housing near the battery compartment may crack, and allow moisture to enter.
Cause as FDA categorized it: Process control · Device type: Sensor, Glucose, Invasive (MDS)
18 more recall records with a free account
Published research
The most relevant PubMed records for "Freestyle Navigator"[tiab]. The summary above synthesizes these.
- Electrochemistry in diabetes management.
Heller A, Feldman B · Acc Chem Res · 2010Research Support, Non-U.S. Gov't
- Clinical use of real-time continuous glucose monitoring.
Battelino T, Bolinder J · Curr Diabetes Rev · 2008Review
- FreeStyle Navigator Continuous Glucose Monitoring System with TRUstart algorithm, a 1-hour warm-up time.
Geoffrey M, Brazg R, Richard W · J Diabetes Sci Technol · 2011Clinical Trial, Multicenter Study
- The development of a glucose prediction model in critically ill patients.
van den Boorn M, Lagerburg V, van Steen SCJ, et al. · Comput Methods Programs Biomed · 2021Randomized Controlled Trial
- Detection of a meal using continuous glucose monitoring: implications for an artificial beta-cell.
Dassau E, Bequette BW, Buckingham BA, et al. · Diabetes Care · 2008Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- Graphical and numerical evaluation of continuous glucose sensing time lag.
Kovatchev BP, Shields D, Breton M · Diabetes Technol Ther · 2009Research Support, N.I.H., Extramural
- In silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes.
Kovatchev BP, Breton M, Man CD, et al. · J Diabetes Sci Technol · 2009Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- The chemistry of commercial continuous glucose monitors.
McGarraugh G · Diabetes Technol Ther · 2009
- Use of continuous glucose monitoring as an outcome measure in clinical trials.
Beck RW, Calhoun P, Kollman C · Diabetes Technol Ther · 2012Comparative Study, Research Support, Non-U.S. Gov't
- Feasibility of prolonged continuous glucose monitoring in toddlers with type 1 diabetes.
Tsalikian E, Fox L, Weinzimer S, et al. · Pediatr Diabetes · 2012Multicenter Study, Research Support, N.I.H., Extramural
- Diabetes research in children network:availability of protocol data sets.
Ruedy KJ, Beck RW, Xing D, et al. · J Diabetes Sci Technol · 2007
- Prolonged use of continuous glucose monitors in children with type 1 diabetes on continuous subcutaneous insulin infusion or intensive multiple-daily injection therapy.
Weinzimer S, Xing D, Tansey M, et al. · Pediatr Diabetes · 2009Research Support, N.I.H., Extramural
Other devices of this type
Also filed under product code MDS.
- Dexcom G4 Platinum Continuous Glucose Monitoring System and Dexcom 5 Mobile Continuous Glucose Monitoring SystemDexcom, Inc. · PMA 2018
- G5 Mobile Continuous Glucose Monitoring SystemDexcom, Inc. · PMA 2024
- FreeStyle Libre Pro Flash Glucose Monitoring SystemAbbott Diabetes Care, Inc. · PMA 2020
- Paradigm Real-Time Insulin PumpMedtronic Minimed · PMA 2015
- Medtronic Minimed Continuous Glucose Monitoring SystemMedtronic Minimed · PMA 2011
- Guardian Connect SystemMedtronic Minimed · PMA 2025
- Dexcom Seven SystemDexcom, Inc. · PMA 2009
- Guardian RtMedtronic Minimed · PMA 2006
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.